Geratherm Medical AG (GME.DE)
EUR 2.84
(-4.38%)
EUR 2.84
(-4.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.18 Million EUR | 19.35% |
| 2022 | 3.36 Million EUR | 24.39% |
| 2021 | 2.19 Million EUR | -45.75% |
| 2020 | 4.34 Million EUR | 78.74% |
| 2019 | 2.57 Million EUR | -16.68% |
| 2018 | 2.66 Million EUR | 33.25% |
| 2017 | 2.04 Million EUR | -41.44% |
| 2016 | 4.57 Million EUR | 10.54% |
| 2015 | 4.52 Million EUR | 5.49% |
| 2014 | 3.33 Million EUR | 113.09% |
| 2013 | 2.34 Million EUR | -19.98% |
| 2012 | 2.35 Million EUR | -29.51% |
| 2011 | 2.6 Million EUR | -35.24% |
| 2010 | 4.02 Million EUR | 106.12% |
| 2009 | 3.3 Million EUR | 99.53% |
| 2008 | 897.36 Thousand EUR | -83.3% |
| 2007 | 1.76 Million EUR | 3.47% |
| 2006 | 2.3 Million EUR | 183.86% |
| 2005 | 1.8 Million EUR | 3.82% |
| 2004 | 1.76 Million EUR | -8.32% |
| 2003 | 2.09 Million EUR | 15.83% |
| 2002 | 1.8 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | 960.1 Thousand EUR | 0.0% |
| 2023 Q1 | 960.1 Thousand EUR | 32.85% |
| 2023 FY | - EUR | 19.35% |
| 2023 Q4 | 1.01 Million EUR | 0.0% |
| 2023 Q3 | 1.01 Million EUR | 5.2% |
| 2022 Q2 | 755.92 Thousand EUR | -33.27% |
| 2022 Q1 | 1.13 Million EUR | 265.26% |
| 2022 FY | - EUR | 24.39% |
| 2022 Q4 | 722.68 Thousand EUR | -7.27% |
| 2022 Q3 | 779.37 Thousand EUR | 3.1% |
| 2021 Q2 | 673.13 Thousand EUR | -35.94% |
| 2021 Q1 | 1.05 Million EUR | -15.33% |
| 2021 Q4 | -685.45 Thousand EUR | -160.78% |
| 2021 Q3 | 1.12 Million EUR | 67.54% |
| 2021 FY | - EUR | -45.75% |
| 2020 Q1 | 670.92 Thousand EUR | 234.31% |
| 2020 Q2 | 1.38 Million EUR | 105.92% |
| 2020 Q3 | 1 Million EUR | -27.55% |
| 2020 Q4 | 1.24 Million EUR | 23.98% |
| 2020 FY | - EUR | 78.74% |
| 2019 FY | - EUR | -16.68% |
| 2019 Q4 | 200.69 Thousand EUR | -67.62% |
| 2019 Q1 | 1.23 Million EUR | 21.48% |
| 2019 Q3 | 619.78 Thousand EUR | 92.15% |
| 2019 Q2 | 322.54 Thousand EUR | -73.8% |
| 2018 Q3 | 295.6 Thousand EUR | -61.35% |
| 2018 FY | - EUR | 33.25% |
| 2018 Q1 | 775.34 Thousand EUR | 303.34% |
| 2018 Q2 | 764.88 Thousand EUR | -1.35% |
| 2018 Q4 | 1.01 Million EUR | 242.82% |
| 2017 Q4 | -381.29 Thousand EUR | -149.46% |
| 2017 Q3 | 770.88 Thousand EUR | 137.54% |
| 2017 FY | - EUR | -41.44% |
| 2017 Q2 | 324.53 Thousand EUR | -74.97% |
| 2017 Q1 | 1.29 Million EUR | 44.8% |
| 2016 Q3 | 607.3 Thousand EUR | -57.4% |
| 2016 Q1 | 723.11 Thousand EUR | 33.83% |
| 2016 FY | - EUR | 10.54% |
| 2016 Q4 | 895.3 Thousand EUR | 47.42% |
| 2016 Q2 | 1.42 Million EUR | 97.14% |
| 2015 FY | - EUR | 5.49% |
| 2015 Q4 | 540.34 Thousand EUR | -34.13% |
| 2015 Q3 | 820.28 Thousand EUR | -19.1% |
| 2015 Q2 | 1.01 Million EUR | 9.11% |
| 2015 Q1 | 929.32 Thousand EUR | 11.2% |
| 2014 Q3 | 864.53 Thousand EUR | -6.21% |
| 2014 Q4 | 835.71 Thousand EUR | -3.33% |
| 2014 Q2 | 921.77 Thousand EUR | 81.03% |
| 2014 Q1 | 509.18 Thousand EUR | 183.13% |
| 2014 FY | - EUR | 113.09% |
| 2013 Q4 | 179.83 Thousand EUR | -43.3% |
| 2013 Q3 | 317.17 Thousand EUR | -7.51% |
| 2013 Q2 | 342.93 Thousand EUR | -45.57% |
| 2013 Q1 | 630.03 Thousand EUR | -38.31% |
| 2013 FY | - EUR | -19.98% |
| 2012 Q3 | 158.17 Thousand EUR | -53.31% |
| 2012 Q4 | 1.02 Million EUR | 545.69% |
| 2012 FY | - EUR | -29.51% |
| 2012 Q1 | 336.94 Thousand EUR | -42.04% |
| 2012 Q2 | 338.79 Thousand EUR | 0.55% |
| 2011 Q4 | 581.37 Thousand EUR | 12.54% |
| 2011 Q3 | 516.6 Thousand EUR | -14.67% |
| 2011 Q1 | 778.84 Thousand EUR | -93.01% |
| 2011 FY | - EUR | -35.24% |
| 2011 Q2 | 605.4 Thousand EUR | -22.27% |
| 2010 FY | - EUR | 106.12% |
| 2010 Q4 | 11.13 Million EUR | 1077.72% |
| 2010 Q3 | 945.43 Thousand EUR | -14.46% |
| 2010 Q2 | 1.1 Million EUR | -6.49% |
| 2010 Q1 | 1.18 Million EUR | 39.12% |
| 2009 Q2 | 653.42 Thousand EUR | 387.93% |
| 2009 Q1 | 133.91 Thousand EUR | 0.0% |
| 2009 Q3 | 855.38 Thousand EUR | 30.91% |
| 2009 FY | - EUR | 99.53% |
| 2009 Q4 | 849.57 Thousand EUR | -0.68% |
| 2008 FY | - EUR | -83.3% |
| 2008 Q2 | 288.85 Thousand EUR | 0.0% |
| 2007 FY | - EUR | 3.47% |
| 2006 FY | - EUR | 183.86% |
| 2005 FY | - EUR | 3.82% |
| 2004 FY | - EUR | -8.32% |
| 2003 FY | - EUR | 15.83% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| aap Implantate AG | -3.43 Million EUR | 221.923% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 98.686% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 98.686% |
| elexxion AG | -860.59 Thousand EUR | 586.218% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 57.48 Million EUR | 92.721% |
| Koninklijke Philips N.V. | 1.04 Billion EUR | 99.598% |
| Stratec SE | 39.82 Million EUR | 89.492% |
| Siemens Healthineers AG | 4.22 Billion EUR | 99.901% |